[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Daniel K. Nomura<\/i><\/u><\/presenter>. University of California, Berkeley, Berkeley, CA","CSlideId":"","ControlKey":"7e084010-3f5b-4d50-96ea-bfaf8e176722","ControlNumber":"289","DisclosureBlock":"&nbsp;<b>&nbsp;D.K. Nomura:<\/b>  ; Frontier Medicines. ; Frontier Medicines. ; Frontier Medicines. ; Vicinitas Therapeutics. ; Vicinitas Therapeutics. ; Vicinitas Therapeutics.","End":"4\/15\/2023 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"178","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Daniel Nomura, PhD","PresenterKey":"3dd15697-fb18-407e-9fd5-3b4b6e2e601d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Daniel K. Nomura<\/i><\/u><\/presenter>. UC Berkeley, Berkeley, CA","CSlideId":"","ControlKey":"91be62db-6124-4e0f-a068-77bcd922745a","ControlNumber":"10382","DisclosureBlock":"<b>&nbsp;D. K. Nomura, <\/b> <br><b>Frontier Medicines<\/b> S, S, S. <br><b>Vicinitas Therapeutics<\/b> S, S, S.","End":"4\/15\/2023 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"9154","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Daniel Nomura, PhD","PresenterKey":"3dd15697-fb18-407e-9fd5-3b4b6e2e601d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Ekaterina V. Vinogradova<\/i><\/u><\/presenter>. The Rockefeller University, New York, NY","CSlideId":"","ControlKey":"5624207d-4213-4ae1-9b5e-aab4da098654","ControlNumber":"8888","DisclosureBlock":"","End":"4\/15\/2023 3:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"1890","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Ekaterina Vinogradova, PhD","PresenterKey":"7ba2afb4-0d7f-4f37-b7dd-8a26050cb129","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Covalent small-molecule protein degraders","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 2:31:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Covalent small-molecule protein degraders","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"8785aa97-6a27-4a63-8016-f1e87720b903","ControlNumber":"10077","DisclosureBlock":"","End":"4\/15\/2023 3:10:00 PM","HasWebcast":null,"Highlights":[],"Id":"8397","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 3:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Daniel K. Nomura<\/i><\/u><\/presenter>. University of California, Berkeley, Berkeley, CA","CSlideId":"","ControlKey":"4ebcf550-3cb4-4fd5-866d-a50dcec7a75d","ControlNumber":"984","DisclosureBlock":"<b>&nbsp;D. K. Nomura, <\/b> <br><b>Frontier Medicines<\/b> S, S, S. <br><b>Vicinitas Therapeutics<\/b> S, S, S.","End":"4\/15\/2023 3:40:00 PM","HasWebcast":null,"Highlights":[],"Id":"424","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Daniel Nomura, PhD","PresenterKey":"3dd15697-fb18-407e-9fd5-3b4b6e2e601d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Reimagining druggability using chemoproteomic platforms","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 3:10:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Reimagining druggability using chemoproteomic platforms","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"d4bc2e5e-a924-43a3-acc6-9d54415e242d","ControlNumber":"10078","DisclosureBlock":"","End":"4\/15\/2023 3:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"8398","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 3:40:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Patrick T. Gunning<\/i><\/u><\/presenter>. University of Toronto Mississauga, Mississauga, ON, Canada","CSlideId":"","ControlKey":"82beb7ba-cb06-436e-8db8-5dcfed22a61a","ControlNumber":"11478","DisclosureBlock":"","End":"4\/15\/2023 3:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"11241","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Patrick Gunning, PhD","PresenterKey":"3a30dbc7-a970-4612-b2a6-4a9b065c45bb","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"<i>Unable to Attend<\/i>","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023  2:30PM","SessionId":"147","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 3 of 3: Covalency and Target Validation","ShowChatLink":"false","Start":"4\/15\/2023 3:50:00 PM","Status":"UnableToAttend","Tags":null,"ThumbnailUrl":null,"Title":"<i>Unable to Attend<\/i>","Topics":null,"cSlideId":""}]